Cargando…

Zika virus infection elicits auto-antibodies to C1q

Zika virus (ZIKV) causes mostly asymptomatic infection or mild febrile illness. However, with an increasing number of patients, various clinical features such as microcephaly, Guillain-Barré syndrome and thrombocytopenia have also been reported. To determine which host factors are related to pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Koma, Takaaki, Veljkovic, Veljko, Anderson, Danielle E., Wang, Lin-Fa, Rossi, Shannan L., Shan, Chao, Shi, Pei-Yong, Beasley, David W., Bukreyeva, Natalya, Smith, Jeanon N., Hallam, Steven, Huang, Cheng, von Messling, Veronika, Paessler, Slobodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789871/
https://www.ncbi.nlm.nih.gov/pubmed/29382894
http://dx.doi.org/10.1038/s41598-018-20185-8
_version_ 1783296367171469312
author Koma, Takaaki
Veljkovic, Veljko
Anderson, Danielle E.
Wang, Lin-Fa
Rossi, Shannan L.
Shan, Chao
Shi, Pei-Yong
Beasley, David W.
Bukreyeva, Natalya
Smith, Jeanon N.
Hallam, Steven
Huang, Cheng
von Messling, Veronika
Paessler, Slobodan
author_facet Koma, Takaaki
Veljkovic, Veljko
Anderson, Danielle E.
Wang, Lin-Fa
Rossi, Shannan L.
Shan, Chao
Shi, Pei-Yong
Beasley, David W.
Bukreyeva, Natalya
Smith, Jeanon N.
Hallam, Steven
Huang, Cheng
von Messling, Veronika
Paessler, Slobodan
author_sort Koma, Takaaki
collection PubMed
description Zika virus (ZIKV) causes mostly asymptomatic infection or mild febrile illness. However, with an increasing number of patients, various clinical features such as microcephaly, Guillain-Barré syndrome and thrombocytopenia have also been reported. To determine which host factors are related to pathogenesis, the E protein of ZIKV was analyzed with the Informational Spectrum Method, which identifies common information encoded by primary structures of the virus and the respective host protein. The data showed that the ZIKV E protein and the complement component C1q cross-spectra are characterized by a single dominant peak at the frequency F = 0.338, suggesting similar biological properties. Indeed, C1q-specific antibodies were detected in sera obtained from mice and monkeys infected with ZIKV. As C1q has been known to be involved not only in immunity, but also in synaptic organization and different autoimmune diseases, a ZIKV-induced anti-C1q antibody response may contribute to the neurological complications. These findings might also be exploited for the design of safe and efficacious vaccines in the future.
format Online
Article
Text
id pubmed-5789871
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57898712018-02-15 Zika virus infection elicits auto-antibodies to C1q Koma, Takaaki Veljkovic, Veljko Anderson, Danielle E. Wang, Lin-Fa Rossi, Shannan L. Shan, Chao Shi, Pei-Yong Beasley, David W. Bukreyeva, Natalya Smith, Jeanon N. Hallam, Steven Huang, Cheng von Messling, Veronika Paessler, Slobodan Sci Rep Article Zika virus (ZIKV) causes mostly asymptomatic infection or mild febrile illness. However, with an increasing number of patients, various clinical features such as microcephaly, Guillain-Barré syndrome and thrombocytopenia have also been reported. To determine which host factors are related to pathogenesis, the E protein of ZIKV was analyzed with the Informational Spectrum Method, which identifies common information encoded by primary structures of the virus and the respective host protein. The data showed that the ZIKV E protein and the complement component C1q cross-spectra are characterized by a single dominant peak at the frequency F = 0.338, suggesting similar biological properties. Indeed, C1q-specific antibodies were detected in sera obtained from mice and monkeys infected with ZIKV. As C1q has been known to be involved not only in immunity, but also in synaptic organization and different autoimmune diseases, a ZIKV-induced anti-C1q antibody response may contribute to the neurological complications. These findings might also be exploited for the design of safe and efficacious vaccines in the future. Nature Publishing Group UK 2018-01-30 /pmc/articles/PMC5789871/ /pubmed/29382894 http://dx.doi.org/10.1038/s41598-018-20185-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Koma, Takaaki
Veljkovic, Veljko
Anderson, Danielle E.
Wang, Lin-Fa
Rossi, Shannan L.
Shan, Chao
Shi, Pei-Yong
Beasley, David W.
Bukreyeva, Natalya
Smith, Jeanon N.
Hallam, Steven
Huang, Cheng
von Messling, Veronika
Paessler, Slobodan
Zika virus infection elicits auto-antibodies to C1q
title Zika virus infection elicits auto-antibodies to C1q
title_full Zika virus infection elicits auto-antibodies to C1q
title_fullStr Zika virus infection elicits auto-antibodies to C1q
title_full_unstemmed Zika virus infection elicits auto-antibodies to C1q
title_short Zika virus infection elicits auto-antibodies to C1q
title_sort zika virus infection elicits auto-antibodies to c1q
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789871/
https://www.ncbi.nlm.nih.gov/pubmed/29382894
http://dx.doi.org/10.1038/s41598-018-20185-8
work_keys_str_mv AT komatakaaki zikavirusinfectionelicitsautoantibodiestoc1q
AT veljkovicveljko zikavirusinfectionelicitsautoantibodiestoc1q
AT andersondaniellee zikavirusinfectionelicitsautoantibodiestoc1q
AT wanglinfa zikavirusinfectionelicitsautoantibodiestoc1q
AT rossishannanl zikavirusinfectionelicitsautoantibodiestoc1q
AT shanchao zikavirusinfectionelicitsautoantibodiestoc1q
AT shipeiyong zikavirusinfectionelicitsautoantibodiestoc1q
AT beasleydavidw zikavirusinfectionelicitsautoantibodiestoc1q
AT bukreyevanatalya zikavirusinfectionelicitsautoantibodiestoc1q
AT smithjeanonn zikavirusinfectionelicitsautoantibodiestoc1q
AT hallamsteven zikavirusinfectionelicitsautoantibodiestoc1q
AT huangcheng zikavirusinfectionelicitsautoantibodiestoc1q
AT vonmesslingveronika zikavirusinfectionelicitsautoantibodiestoc1q
AT paesslerslobodan zikavirusinfectionelicitsautoantibodiestoc1q